Classic mycosis fungoides
Learn about Classic mycosis fungoides, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: Mycosis fungoides, Alibert-Bazin type
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis. Ask the treating doctor about these.
What it is
From: Orphanet
A form of cutaneous T-cell lymphoma characterized by slow progression from patches to more infiltrated plaques and eventually to tumors. In classic mycosis fungoides (MF), extracutaneous involvement may occur.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Abnormal lymphocyte morphology · Very frequent (99-80%)
- An abnormality of lymphocytes.
- Dry skin · Very frequent (99-80%)
- Skin characterized by the lack of natural or normal moisture.
- Eczematoid dermatitis · Very frequent (99-80%)
- Eczema is a form of dermatitis that is characterized by scaly, pruritic, erythematous lesions located on flexural surfaces.
- Erythema · Very frequent (99-80%)
- Redness of the skin, caused by hyperemia of the capillaries in the lower layers of the skin.
- Lymphoma · Very frequent (99-80%)
- A cancer originating in lymphocytes and presenting as a solid tumor of lymhpoid cells.
- Neoplasm of the skin · Very frequent (99-80%)
- A tumor (abnormal growth of tissue) of the skin.
- Pruritus · Very frequent (99-80%)
- Pruritus is an itch or a sensation that makes a person want to scratch. This term refers to an abnormally increased disposition to experience pruritus.
- Skin plaque · Very frequent (99-80%)
- A plaque is a solid, raised, plateau-like (flat-topped) lesion greater than 1 cm in diameter.
- Skin rash · Very frequent (99-80%)
- A red eruption of the skin.
- Alopecia · Frequent (79-30%)
- A noncongenital process of hair loss, which may progress to partial or complete baldness.
- Cutaneous T-cell lymphoma · Frequent (79-30%)
- A type of T-cell lymphoma that exhibits malignant infiltration of the skin.
- Erythematous macule · Frequent (79-30%)
- A macule (flat, distinct, discolored area of skin less than 1 cm wide that does not involve any change in the thickness or texture of the skin) with a red or reddish color often associated with inflammation or irritation.
- Lymphadenopathy · Frequent (79-30%)
- Enlargement (swelling) of a lymph node.
- Poikiloderma · Frequent (79-30%)
- Poikiloderma refers to a patch of skin with (1) reticulated hypopigmentation and hyperpigmentation, (2) wrinkling secondary to epidermal atrophy, and (3) telangiectasias.
Other findings in the same source
From: Orphanet
Additional reported features include Hypopigmented skin patches (Frequent (79-30%)); Irregular hyperpigmentation (Frequent (79-30%)); Abnormal eyelid morphology (Occasional (29-5%)); Abnormal nail morphology (Occasional (29-5%)); Abnormality of bone marrow cell morphology (Occasional (29-5%)); Edema (Occasional (29-5%)); Erythroderma (Occasional (29-5%)); Hepatomegaly (Occasional (29-5%)); Hyperkeratosis (Occasional (29-5%)); Skin ulcer (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Adult
Inheritance in the source
From: Orphanet
Multigenic/multifactorial; Not applicable
Frequency and the population described
From: Orphanet
Annual incidence: 1-9 / 1 000 000; United States; Value and class. Annual incidence: 1-9 / 1 000 000; Europe; Value and class. Point prevalence: Unknown; Worldwide; Class only.
Which doctor should you see?
The suggested department for discussing Classic mycosis fungoides is Oncology, with a oncologist and relevant organ specialist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
Additional services that may be relevant, depending on the findings, include: Clinical Genetics; Relevant organ specialist / Surgical Oncology as indicated.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Has the exact tumour type been confirmed, and is staging relevant?
- What is the goal of each proposed treatment option?
- How will side effects, daily function and supportive care be addressed?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for Classic mycosis fungoides. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
Oncology is not listed separately on The Doctor Index; the nearest speciality is medical oncology. Every profile shows the doctor’s registration and what has been checked.
Sources
- Orphanet — Classic mycosis fungoides — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-0528.